132 related articles for article (PubMed ID: 30311951)
1. Incidence of immune thrombocytopenia in Taiwan: a nationwide population-based study.
Hung GY; Lee CY; Yen HJ; Lin LY; Horng JL
Transfusion; 2018 Nov; 58(11):2712-2719. PubMed ID: 30311951
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
Moulis G; Palmaro A; Montastruc JL; Godeau B; Lapeyre-Mestre M; Sailler L
Blood; 2014 Nov; 124(22):3308-15. PubMed ID: 25305203
[TBL] [Abstract][Full Text] [Related]
3. Incidence, clinical characteristics, and associated diseases in patients with immune thrombocytopenia: A nationwide population-based study in Taiwan.
Wu SR; Kuo HC; Huang WC; Huang YF; Chiou YH; Chang YH; Nong BR
Thromb Res; 2018 Apr; 164():90-95. PubMed ID: 29522912
[TBL] [Abstract][Full Text] [Related]
4. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea.
Lee JY; Lee JH; Lee H; Kang B; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Choi HS; Lee JS; Bang SM
Thromb Res; 2017 Jul; 155():86-91. PubMed ID: 28525829
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database.
Yong M; Schoonen WM; Li L; Kanas G; Coalson J; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2010 Jun; 149(6):855-64. PubMed ID: 20377590
[TBL] [Abstract][Full Text] [Related]
7. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.
Terrell DR; Beebe LA; Vesely SK; Neas BR; Segal JB; George JN
Am J Hematol; 2010 Mar; 85(3):174-80. PubMed ID: 20131303
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
9. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States.
Shaw J; Kilpatrick K; Eisen M; Tarantino M
Platelets; 2020; 31(3):307-314. PubMed ID: 31271328
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
[TBL] [Abstract][Full Text] [Related]
12. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis.
Weycker D; Hanau A; Hatfield M; Wu H; Sharma A; Bensink ME; Chandler D; Grossman A; Tarantino M
J Med Econ; 2020 Feb; 23(2):184-192. PubMed ID: 31547724
[No Abstract] [Full Text] [Related]
13. Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP).
Enger C; Bennett D; Dawson KL; Aivado MA; Theodore D; McAfee AT
Ann Hepatol; 2011; 10(2):188-95. PubMed ID: 21502681
[TBL] [Abstract][Full Text] [Related]
14. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
Dayama A; Dass J; Mahapatra M; Saxena R
Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.
Ahmed R; Devasia AJ; Viswabandya A; Lakshmi KM; Abraham A; Karl S; Mathai J; Jacob PM; Abraham D; Srivastava A; Mathews V; George B
Ann Hematol; 2016 Sep; 95(9):1429-34. PubMed ID: 27370992
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
Schoonen WM; Kucera G; Coalson J; Li L; Rutstein M; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2009 Apr; 145(2):235-44. PubMed ID: 19245432
[TBL] [Abstract][Full Text] [Related]
20. Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group.
Ben-Yehuda D; Gillis S; Eldor A
Acta Haematol; 1994; 91(1):1-6. PubMed ID: 8171929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
